Nkarta, Inc.
NKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787400
No open-market purchases or sales by Nkarta, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Nkarta, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −3 vs. Q1 2023
- Shares held
- 39.5M
- −1.89M (−4.6%) vs. Q1 2023
- Total value
- $86.5M
- −$60.4M (−41.1%) vs. Q1 2023
- New holders
- 18
- 27 more added
- Sold out
- 21
- 37 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $167.9M |
| Q1 2026 | 126 | $121.6M |
| Q4 2025 | 119 | $103.2M |
| Q3 2025 | 120 | $119.4M |
| Q2 2025 | 104 | $96.9M |
| Q1 2025 | 111 | $113.2M |
| Q4 2024 | 112 | $154.8M |
| Q3 2024 | 119 | $301.7M |
| Q2 2024 | 112 | $391.5M |
| Q1 2024 | 115 | $687.1M |
| Q4 2023 | 94 | $270.2M |
| Q3 2023 | 85 | $50.7M |
| Q2 2023 | 97 | $86.5M |
| Q1 2023 | 100 | $147.0M |
| Q4 2022 | 121 | $251.9M |
| Q3 2022 | 105 | $561.5M |
| Q2 2022 | 115 | $536.7M |
| Q1 2022 | 84 | $287.2M |
| Q4 2021 | 92 | $366.5M |
| Q3 2021 | 87 | $651.4M |
| Q2 2021 | 89 | $764.7M |
| Q1 2021 | 97 | $866.8M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Nkarta, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −104,935−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −96,068−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −80,102−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −75,854−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −69,571−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −46,062−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −33,166−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −28,265−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −23,587−100.0% | Sold out |
| AtonRa Partners | 0 | $0 | 0.00% | −20,111−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −13,821−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −13,557−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,936−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −4,470−100.0% | Sold out |
| Slow Capital, Inc. | 0 | $0 | 0.00% | −453−100.0% | Sold out |
| Pinnacle Bancorp, Inc. | 0 | $0 | 0.00% | −227−100.0% | Sold out |